Matches in Wikidata for { <http://www.wikidata.org/entity/Q66066826> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q66066826 description "clinical trial" @default.
- Q66066826 description "ensayu clínicu" @default.
- Q66066826 description "klinisch onderzoek" @default.
- Q66066826 description "клінічне випробування" @default.
- Q66066826 name "Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults" @default.
- Q66066826 name "Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus" @default.
- Q66066826 type Item @default.
- Q66066826 label "Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults" @default.
- Q66066826 label "Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus" @default.
- Q66066826 prefLabel "Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults" @default.
- Q66066826 prefLabel "Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus" @default.
- Q66066826 P1132 Q66066826-EB9D99C5-EEF4-4B0E-83D7-A607ECE24CB2 @default.
- Q66066826 P1476 Q66066826-D667DFC2-2495-4FFE-8217-68791C2B952F @default.
- Q66066826 P2899 Q66066826-DC8F0B0E-E73C-4804-8F8C-E98FAA50A08B @default.
- Q66066826 P3098 Q66066826-E720BAEA-0A37-4212-83DA-9531E1D67D50 @default.
- Q66066826 P31 Q66066826-1B6DCCBE-0A79-46F4-8D59-9CE19695B3A5 @default.
- Q66066826 P580 Q66066826-A10CBF27-C849-4C59-A8F6-47AC283280AC @default.
- Q66066826 P582 Q66066826-DEE9A922-A63C-464C-8237-516F92AA5444 @default.
- Q66066826 P6099 Q66066826-F6E7B871-BB5F-4382-8BD7-7DCC97D4DA33 @default.
- Q66066826 P6153 Q66066826-3F8832F9-97B8-42B9-9469-0E309F5BE410 @default.
- Q66066826 P8363 Q66066826-AB6DD1BE-93FA-4C52-A3B7-7F133D33275C @default.
- Q66066826 P1132 "+120" @default.
- Q66066826 P1476 "A Phase 3b Multi-center, Open Label, Single Arm, 48-week Study, Evaluating the Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using Fixed Dose Dolutegravir Plus Lamivudine as a First Line Regimen" @default.
- Q66066826 P2899 "+18" @default.
- Q66066826 P3098 "NCT03945981" @default.
- Q66066826 P31 Q30612 @default.
- Q66066826 P580 "2019-06-25T00:00:00Z" @default.
- Q66066826 P582 "2020-08-03T00:00:00Z" @default.
- Q66066826 P6099 Q42824827 @default.
- Q66066826 P6153 Q212322 @default.
- Q66066826 P8363 Q78089383 @default.